Active pathogenic inflammasomes can be further modulated by deubiquitination and signals associated with pathogens or sterile triggers that activate the NF-κB pathway, intensifying inflammasome-related responses, including IL-1β production and CAPS flares. This evidence concerns the gene NFKB1 and cryopyrin-associated periodic syndrome.